` TCMD (Tactile Systems Technology Inc) vs S&P 500 Comparison - Alpha Spread

TCMD
vs
S&P 500

Over the past 12 months, TCMD has significantly outperformed S&P 500, delivering a return of +56% compared to the S&P 500's +12% growth.

Stocks Performance
TCMD vs S&P 500

Loading
TCMD
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TCMD vs S&P 500

Loading
TCMD
S&P 500
Difference
www.alphaspread.com

Performance By Year
TCMD vs S&P 500

Loading
TCMD
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Tactile Systems Technology Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Tactile Systems Technology Inc
Glance View

Market Cap
621.4m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
23.54 USD
Overvaluation 15%
Intrinsic Value
Price
Back to Top